Pearl River Capital, LLC Amgen Inc Transaction History

Pearl River Capital, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $2.56 Million - $3.26 Million	11,195 Added 145.54%	18,887 $4.96 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $1.07 Million - $1.2 Million	-4,750 Reduced 38.18%	7,692 $1.73 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $2.87 Million - $3.19 Million	12,442 New	12,442 $3.03 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $1.81 Million - $2.07 Million	-9,115 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $1.93 Million - $2.27 Million	9,115 New	9,115 $1.94 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $2.29 Million - $2.66 Million	-10,297 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $2.23 Million - $2.65 Million	10,297 New	10,297 $2.37 Million
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $12,857 - $15,778	-65 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$182.24 - $241.7 $11,845 - $15,710	65 New	65 $13,000
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $245,594 - $315,673	-1,298 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$174.11 - $208.62 $225,994 - $270,788	1,298 New	1,298 $251,000

3,121

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.